Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2019

Open Access 01-12-2019 | Sectio Ceasarea | Research article

Effect of delayed misoprostol dosing interval for induction of labor: a retrospective study

Authors: Elizabeth H. Harman Crowell, Alexander M. Crowell, Regan N. Theiler

Published in: BMC Pregnancy and Childbirth | Issue 1/2019

Login to get access

Abstract

Background

Induction of labor occurs in greater than 22% of all pregnancies in the United States. Previous studies have shown that misoprostol is more effective for induction than oxytocin or dinoprostone alone. The World Health Organization recommends vaginal misoprostol 25mcg every 6 hours and the American Congress of Obstetricians and Gynecologists recommends 25mcg vaginal misoprostol every three to 6 hours. Although route of administration and dosage of misoprostol has been extensively studied, little is known about the optimal dosing interval of vaginal misoprostol.

Methods

The primary objective of this study is to determine the effect of delayed vaginal misoprostol dosing, defined as any interval longer than 4.5 h, on time to vaginal delivery. Our hypothesis is that the routine dosing interval of 4 hours shortens times to vaginal delivery compared to delayed dosing, even when adjusted for the time of delay. Secondary objectives include the effect of delayed vaginal misoprostol dosing on cesarean section rate, operative vaginal delivery rate, maternal outcomes, and neonatal outcomes.
We conducted a retrospective chart review of 323 inductions of labor at one academic institution. The primary outcome was the proportion of patients who achieved a vaginal delivery within 24 h. The group who received all doses of misoprostol within a 4.5 h dosing window (Routine Dosing Interval Group) was compared with the group who had any dosing deviation (Delayed Dosing Interval Group).

Results

Of 133 included patients, 64 subjects received routine interval dosing and 69 subjects received delayed interval dosing. The vaginal delivery rates within 24 h were 56% (36/64) and 20% (14/69), respectively (P < 10− 4). Spontaneous vaginal delivery rates were 86% (55/64) vs. 75% (52/69), respectively (P = .13). Kaplan Meier curves demonstrated statistically significant difference in time to vaginal delivery between groups, with a Cox Proportional Hazard ratio for routine dosing interval of 1.73 (P < 10− 5) unadjusted and 1.34 (P = .01) when adjusted for dosing delay.

Conclusions

This retrospective study demonstrates a significant increase in delay-adjusted time to vaginal delivery when doses of vaginal misoprostol are delayed past 4.5 h.
Appendix
Available only for authorised users
Literature
1.
go back to reference ACOG, Induction of labor: Practice bulletin 107, number 107, 2009. ACOG, Induction of labor: Practice bulletin 107, number 107, 2009.
2.
go back to reference Hofmeyr GJ, et al. Vaginal misoprostol for cervical ripening and induction of labor (review). Cochrane Libr. 2013;10. Hofmeyr GJ, et al. Vaginal misoprostol for cervical ripening and induction of labor (review). Cochrane Libr. 2013;10.
3.
go back to reference Balci O, et al. Comparison of induction of labor with vaginal misoprostol plus oxytocin versus oxytocin in term primigravide. J Matern Fetal Neonatal Med. 2011;24(9):1084–187.CrossRef Balci O, et al. Comparison of induction of labor with vaginal misoprostol plus oxytocin versus oxytocin in term primigravide. J Matern Fetal Neonatal Med. 2011;24(9):1084–187.CrossRef
4.
go back to reference Elati A, Weeks A. The use of misoprostol in obstetrics and gynaecology. BJOG. 2009;116(Suppl. 1):61–9.CrossRef Elati A, Weeks A. The use of misoprostol in obstetrics and gynaecology. BJOG. 2009;116(Suppl. 1):61–9.CrossRef
5.
go back to reference Khan R-U, et al. Oral, Rectal, and Vaginal Pharmacokinetics. Obstet Gyn. 2004;103(5):866–70.CrossRef Khan R-U, et al. Oral, Rectal, and Vaginal Pharmacokinetics. Obstet Gyn. 2004;103(5):866–70.CrossRef
6.
go back to reference Marwah S, et al. A comparative study to evaluate the efficacyof vaginal vs oral prostaglandin E1 analogue(misoprostol) in management of first trimester missed abortion. J Clin Diagn Res. 2016;10(5):QC14–8.PubMedPubMedCentral Marwah S, et al. A comparative study to evaluate the efficacyof vaginal vs oral prostaglandin E1 analogue(misoprostol) in management of first trimester missed abortion. J Clin Diagn Res. 2016;10(5):QC14–8.PubMedPubMedCentral
7.
go back to reference McMaster K, Sanchez-Ramos L, Kaunitz AM. Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour. BJOG. 2014;122:468–76.CrossRef McMaster K, Sanchez-Ramos L, Kaunitz AM. Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour. BJOG. 2014;122:468–76.CrossRef
10.
go back to reference Peritt J, Burke A, Edelman A. Interruption of nonviable pregnancies of 24–28 weeks' gestation using medical methods. Contraception. 1988;88:341–9.CrossRef Peritt J, Burke A, Edelman A. Interruption of nonviable pregnancies of 24–28 weeks' gestation using medical methods. Contraception. 1988;88:341–9.CrossRef
11.
go back to reference Johnson D. Risk of cesarean delivery after induction at term in nulliparous women with an unfavorable cervix. Am J Obstet Gynecol. 2003;188:1565–72.CrossRef Johnson D. Risk of cesarean delivery after induction at term in nulliparous women with an unfavorable cervix. Am J Obstet Gynecol. 2003;188:1565–72.CrossRef
12.
go back to reference Nielsen PE, et al. The distribution and predictive value of bishop scores in Nulliparas between 37 and 42 Weeks Gestatio. J Matern Fetal Neonatal Med. 2012;25(3):281–5.CrossRef Nielsen PE, et al. The distribution and predictive value of bishop scores in Nulliparas between 37 and 42 Weeks Gestatio. J Matern Fetal Neonatal Med. 2012;25(3):281–5.CrossRef
13.
go back to reference Alfirevic Z. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ. 2015;350:h217.CrossRef Alfirevic Z. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ. 2015;350:h217.CrossRef
Metadata
Title
Effect of delayed misoprostol dosing interval for induction of labor: a retrospective study
Authors
Elizabeth H. Harman Crowell
Alexander M. Crowell
Regan N. Theiler
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2019
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-019-2454-9

Other articles of this Issue 1/2019

BMC Pregnancy and Childbirth 1/2019 Go to the issue